LorianVAtkinsonB. Bacterial resistance to antibiotics in the United States. Ten million strains, nine species and sixteen antibiotics. Drugs Exp Clin Res1987; 13: 457–77.
GoldsteinEJCitronDMBendonLVagvolgyiAETrousdaleMDApplemanMD. Potential of topical norfloxacin therapy. Comparative in vitro activity against clinical ocular bacterial isolates. Arch Ophthalmol1987; 105: 991–4.
4.
JensenHOsatoMTTrousdaleMDComparative in vitro activity of ofloxacin with five other antibiotics against ocular bacterial isolates. Invest Ophthalmol Vis Sci1988; 29: 444–9.
5.
MitsuiGKitanoSInagakiM. Study on therapeutic effects and optimal concentration of new synthetic antimicrobial agent. Ofloxacin eye drops in the treatment of external ocular infections. Jpn Rev Clin Ophthalmol1985; 79: 1718–21.
6.
MitsuiGMatsudaHMiyajimaITherapeutic effects of ofloxacin eye drops (DE-055) on external infection of the eye. Multicentral double blind test. Jpn Rev Clin Ophthalmol1986; 80: 1813–20.
7.
MitsuiGSakuragiSTamuraOEffect of ofloxacin ophthalmic solution in the treatment of external bacterial infections of the eye. Folia Ophthalmol Jpn1986; 37: 1115–7.
8.
HaraJ. Phase I study on DE-055 eye drops. Jpn Rev Clin Ophthalmol1985; 79: 1712–5.
9.
TamuraONachikoAB. Preoperative sterilization and prevention of postoperative infection by ofloxacin. Jpn Rev Clin Ophthalmol1986; 80: 104–6.
10.
CagleGDavisSRosenthalASmithJ. Topical tobramycin and gentamicin sulfate in the treatment of ocular infections. Multicenter study. Curr Eye Res1981/82; 1: 523–34.
11.
SchluterG. Ciprofloxacin. Review of potential toxicologic effects. Am J Med1987; 82: 91–3.
